Fig. 7From: Exosomal DNAJB11 promotes the development of pancreatic cancer by modulating the EGFR/MAPK pathwayExosomal DNAJB11 promotes pancreatic cancer growth in a xenograft model. A Subcutaneously implanted tumor 2 weeks after initial implantation. B Surgically excised tumor tissue. C Statistical analysis of the weight of the subcutaneously implanted tumor. D Growth curve of subcutaneously implanted tumors. E Representative image of immunofluorescence staining of DNAJB11 in a paraffin-embedded excised tumor tissue section. *P < 0.05, **P < 0.01; ***P < 0.001, one-way ANOVABack to article page